Subject
- 1 Anti-neutrophil cytoplasmic antibody; connective tissue disease; MPO-ANCA; PR3-ANCA; vasculitis
- 1 antibiyotik direnci multiple drug resistance
- 1 article
- 1 coinfection; respiratory viruses; SARS-CoV-2
- 1 CoronaVac (R)
- 1 COVID-19
- 1 Covid-19
- 1 Dermatomycoses
- 1 dermatomycosis
- 1 growth, development and aging
- . next >
Date issued
Type
- 7 Article
Fulltext
Results 1-7 of 7 (Search time: 0.01 seconds).
Issue Date | Title | Author(s) | |
---|---|---|---|
1 | 2024 | Coinfection with SARS-CoV-2 and common respiratory pathogens in patients with suspected COVID-19 | Öner, S.Z. ; Özdemİr, H. ; Demİr, M. ; Mete, E. ; Kalelİ, İ. ; Çalişkan, A. ; Ergİn, Ç. |
2 | 2024 | Evaluation of ANCA in vasculitis and non-vasculitis diseases | Öner, S.Z. ; Demir, M. ; Özkan, B. ; Mete, E. ; Kaleli, İ. ; Çalışkan, A. ; Ergin, Ç. |
3 | 2004 | Investigation of the inter-observer agreement rates for morphometric evaluation of the growth of Microsporum canis colonies | Ergin, Çağrı. ; Kaleli, İknur.; Akda?, Beyza.; Şengül, Mustafa. ; Cevahir, Nural.; Demir, Melek. ; Mete, Ergun. |
4 | 2004 | Microsporum canis kolonilerinin morfometrik değerlendirmesinde araştırıcı uyumu | Ergin, Çağrı ; Kaleli, İlknur ; Akdağ, Beyza; Şengül, Mustafa ; Cevahir, Nural ; Demir, Melek ; Mete, Ergun |
5 | 2022 | Monitoring SARS CoV-2 antibodies positivity in healthcare workers after inactivated CoronaVac (R) vaccine | Demir, Melek ; Çalışkan, Ahmet ; Kaleli, İlknur ; Dönmez, Büşra ; Er, Hatice ; Ergin, Çağrı |
6 | 2022 | Omicron varyantının RT-PCR ve hızlı antijen testi (ExacTest™ COVID-19 Antijen Hızlı Testi) ile değerlendirilmesi | Öner, Sedef Zeliha ; Dönmez, Büşra ; Kaleli, İlknur ; Demir, Melek ; Mete, Ergun ; Çalışkan, Ahmet ; Ergin, Çağrı |
7 | 2022 | PSEUDOMONAS AERUGINOSA İZOLATLARININ ANTİBİYOTİK DİRENCİ VE YILLAR İÇİNDEKİ DEĞİŞİMİ | Kaleli, İlknur ; Demir, Melek ; Önder, Sedef Zeliha; Mete, Ergün ; Ergin, Çağrı ; Çalışkan, Ahmet |
Claim Researcher Page
Check the encrypted string of this email, put the correct string in the box below and click "Go" to validate the email and claim this profile.
Emails: m d e m * * @ * * * * * * u . t r